Yes, formalin (formaldehyde) is carcinogenic to humans.
Formaldehyde is classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC), meaning there is sufficient evidence that it causes cancer in humans 1.
Specific Cancer Risks
Established Cancers (Sufficient Evidence)
Nasopharyngeal cancer has the strongest evidence linking formaldehyde exposure to cancer in humans. This classification was established in 2004 and has been consistently supported by occupational cohort studies and meta-analyses 1.
Leukemia, particularly myeloid leukemia, was upgraded to "sufficient" evidence in 2009 following:
- Updated U.S. cohort studies of industrial workers
- Nested case-control studies of funeral industry professionals with lifetime embalming exposure
- Meta-analyses showing positive associations with leukemia risk overall and myeloid leukemia specifically 1
The mechanistic evidence is compelling: exposed workers demonstrate numerical chromosomal aberrations in myeloid progenitor cells consistent with myeloid leukemia, along with hematological changes in peripheral blood indicating alterations in cell proliferation and cell death 1.
Limited Evidence Cancers
Sinonasal cancer remains classified with "limited" evidence due to discordant findings between case-control and cohort studies, and concerns about residual confounding from wood dust exposure 1.
Genotoxic Mechanisms
Formaldehyde is genotoxic in human nasal tissues. The carcinogenic pathway involves:
- Direct DNA damage and chromosomal aberrations
- Alterations in cell proliferation and death pathways
- Disruption of nutrient supply to cells
- Multiple genotoxic mechanisms leading to hematological malignancies 1
Occupational Exposure Context
The highest formaldehyde concentrations occur in:
- Waterpipe cafes (1,620,000 μg/m³)
- Anatomy and pathology laboratories (4,237.5 μg/m³)
More than 71% of investigated occupational studies showed carcinogenic risk exceeding acceptable levels (CR = 1.00 × 10⁻⁴) 2.
Dose-Response Relationship
The evidence suggests non-linear exposure-response relationships:
- No increased nasopharyngeal cancer in humans below mean levels of 1 ppm with peaks below 4 ppm
- Lymphohematopoietic malignancies not consistently reported at peak exposures below 2 ppm and average exposures below 0.5 ppm 3
However, the 2009 IARC reevaluation established sufficient evidence for both nasopharyngeal cancer and leukemia based on occupational cohorts with well-characterized exposures 1.
Clinical Implications
Minimize all unnecessary formaldehyde exposure, particularly in occupational settings. The European Union has considered banning formalin due to its carcinogenicity and mutagenic effects, though temporary permission continues for medical-diagnostic use 4. Alternative fixatives like glyoxal acid-free (GAF) solutions are being developed and tested as non-toxic substitutes 4.
Workers in high-exposure occupations (embalmers, pathology laboratory staff, industrial workers) require targeted exposure reduction strategies and surveillance for nasopharyngeal cancer and myeloid leukemia 2, 5.